iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts.

Life Science Alliance
Nicholas J HessJenny E Gumperz

Abstract

Invariant natural killer T (iNKT) cells are a conserved population of innate T lymphocytes that interact with key antigen-presenting cells to modulate adaptive T-cell responses in ways that can either promote protective immunity, or limit pathological immune activation. Understanding the immunological networks engaged by iNKT cells to mediate these opposing functions is a key pre-requisite to effectively using iNKT cells for therapeutic applications. Using a human umbilical cord blood xenotransplantation model, we show here that co-transplanted allogeneic CD4+ iNKT cells interact with monocytes and T cells in the graft to coordinate pro-hematopoietic and immunoregulatory pathways. The nexus of iNKT cells, monocytes, and cord blood T cells led to the release of cytokines (IL-3, GM-CSF) that enhance hematopoietic stem and progenitor cell activity, and concurrently induced PGE2-mediated suppression of T-cell inflammatory responses that limit hematopoietic stem and progenitor cell engraftment. This resulted in successful long-term hematopoietic engraftment without pretransplant conditioning, including multi-lineage human chimerism and colonization of the spleen by antibody-producing human B cells. These results highlight the potent...Continue Reading

References

Jan 1, 1975·The Journal of Allergy and Clinical Immunology·J T Cassidy, G L Nordby
Apr 14, 1994·Biochimica Et Biophysica Acta·J H Exton
Sep 17, 1999·Tissue Antigens·M HanM A Robinson
Oct 28, 2003·Nature Immunology·Manfred BriglMichael B Brenner
Mar 23, 2004·Annual Review of Immunology·Manfred Brigl, Michael B Brenner
Aug 10, 2004·Bone Marrow Transplantation·K HaraguchiH Hirai
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonard D ShultzRupert Handgretinger
Dec 24, 2005·Blood·Ioannis KotsianidisAnastasios Karadimitris
Mar 7, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manfred BriglJenny E Gumperz
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiuxu ChenJenny E Gumperz
Apr 9, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Julia A Brown, Vassiliki A Boussiotis
Mar 10, 2009·Nature Methods·Claudia WaskowHans-Reimer Rodewald
May 26, 2009·Journal of Leukocyte Biology·Subramanya HegdeJenny E Gumperz
Oct 28, 2009·PLoS Biology·Lisa M FoxJenny E Gumperz
Feb 16, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Vivien BeziatUNKNOWN French Minicord Study Group
May 18, 2010·Current Opinion in Hematology·Ellen M Durand, Leonard I Zon
Jan 13, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael R BishopSergio Giralt
Jan 25, 2011·Cellular & Molecular Immunology·Nalu Navarro-Alvarez, Yong-Guang Yang
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tim WillingerRichard A Flavell
Mar 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Claudia de LallaGiulia Casorati
Mar 8, 2012·The EMBO Journal·Jacinto López-SagasetaErin J Adams
May 16, 2013·Blood·Karen K BallenHal E Broxmeyer
Mar 19, 2014·Nature Biotechnology·Anthony RongvauxRichard A Flavell
Jul 16, 2014·Cell Stem Cell·Kadriye Nehir CosgunClaudia Waskow
Feb 13, 2015·Frontiers in Immunology·Abdulraouf Ramadan, Sophie Paczesny
Feb 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie B TsaiAndrew S Artz
Jul 18, 2016·Experimental Hematology·Tiago C LuisGrant A Challen
Nov 25, 2016·Frontiers in Immunology·Mateja Kralj JuricHildegard T Greinix
Dec 15, 2016·Frontiers in Immunology·Tomomi ToubaiPavan Reddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.